In summary, this study reveals that NK-derived exosomal miR-1249-3p attenuates insulin resistance and inflammation through the SKOR1-SMAD6-TLR4-NF-κB axis, and provides a series of potential therapeutic targets in T2D. This evidence concerns the gene SMAD6 and type 2 diabetes mellitus.